Simulations Plus Collaborates with Multinational Pharmaceutical Company to Provide Modeling & Simulation Support for COVID-19 TreatmentBusiness Wire • 06/23/22
Simulations Plus Sets Date for Third Quarter Fiscal Year 2022 Earnings Release and Conference CallBusiness Wire • 06/21/22
Simulations Plus, Inc. (SLP) CEO Shawn O'Connor on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 04/07/22
Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety SoftwareBusiness Wire • 03/29/22
Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific ConferenceBusiness Wire • 03/24/22
Simulations Plus Sets Date for Second Quarter Fiscal Year 2022 Earnings Release and Conference CallBusiness Wire • 03/22/22
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit National Organization for Rare DisordersBusiness Wire • 03/17/22
Simulations Plus to Present at Raymond James Institutional Investors ConferenceBusiness Wire • 03/02/22
Simulations Plus: Software For The Pharma Industry, Significant Upside PotentialSeeking Alpha • 03/01/22
Simulations Plus to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceBusiness Wire • 02/08/22
Simulations Plus Partners with Large Pharmaceutical Company to Drive Advancements to the GastroPlus Mechanistic Oral Absorption ModelBusiness Wire • 01/20/22